According to Fortress Biotech 's latest financial reports the company's total assets are $0.16 B. A companyโs total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Year | Total assets | Change |
---|---|---|
2022-12-31 | $0.29 B | -25.78% |
2021-12-31 | $0.39 B | 18.92% |
2020-12-31 | $0.33 B | 47.25% |
2019-12-31 | $0.22 B | 60.59% |
2018-12-31 | $0.14 B | -42.67% |
2017-12-31 | $0.24 B | 44.06% |
2016-12-31 | $0.17 B | 43.94% |
2015-12-31 | $0.11 B | 32.78% |
2014-12-31 | $89.32 M | -11.19% |
2013-12-31 | $0.10 B | 145.37% |
2012-12-31 | $40.99 M | 75.37% |
2011-12-31 | $23.37 M |
Company | Total assets | differencediff. | Country |
---|---|---|---|
Veracyte VCYT | $1.11 B | 565.51% | ๐บ๐ธ USA |
Dicerna Pharmaceuticals DRNA | N/A | N/A | ๐บ๐ธ USA |
Advaxis ADXS | $16.57 M | -90.10% | ๐บ๐ธ USA |
Dynavax Technologies
DVAX | $0.99 B | 495.19% | ๐บ๐ธ USA |